Artemisinin Resistance

Artemisinin resistance refers to the reduced effectiveness of the main drug used to treat malaria caused by Plasmodium falciparum. Over time, some malaria parasites mutate, making them less responsive to the drug, which can lead to longer infections and increased risk of complications. This resistance complicates malaria control efforts, as it can cause treatments to fail and require alternative medications. Monitoring and managing resistance is vital to ensure effective malaria treatment and prevent the spread of harder-to-treat parasite strains.